PRP vs. Mesotherapy for Hair Loss: Indications, Evidence and Combinations

PRP and mesotherapy are the two injectable regenerative treatments that anchor most hair restoration clinics' non-surgical service line. Both are scalp injections, both follow similar session intervals, both target patients with early-to-moderate hair loss who are not yet candidates for transplantation. The differences matter clinically — and matter operationally for any clinic deciding which to offer, or how to position both. This article is a clinical comparison: indications, evidence, contraindications, and the protocol decisions that shape outcomes.

Mechanism and what's in the syringe

The fundamental difference is what the operator injects.

PRP's active ingredient profile is fixed by the patient's blood. Mesotherapy's is fixed by the cocktail formulation chosen — and most clinics rotate two or three documented formulations rather than improvising per patient.

Indications — where each treatment fits

The clinical indications overlap heavily. Both are appropriate for early-to-moderate androgenetic alopecia, telogen effluvium, post-transplant graft support, and as maintenance between surgical interventions. Where they diverge is patient-specific factors.

PRP fits better for:

• Patients seeking the most evidence-supported option
• Patients with no contraindication to blood draw
• Post-transplant cases where graft survival support is the goal
• Patients comfortable with a longer in-chair time

Mesotherapy fits better for:

• Patients with needle-related anxiety about blood draw
• Patients with hypersensitivity to citrate or other PRP tube anticoagulants
• Cases where the clinical rationale points to nutrient deficiency
• Maintenance phase after a PRP loading course
• Patients who want a shorter appointment

In practice, most working clinics offer both and let patient preference plus clinical fit drive the choice. The protocol foundations for both treatments are covered in PRP and mesotherapy training for clinics.

Evidence base — honest summary

PRP has the stronger published evidence base. Multiple controlled trials in androgenetic alopecia (mostly male, growing female literature) show statistically significant improvement in hair count and shaft thickness over 6–12 months versus placebo or saline injections. Effect sizes are modest — hair density improvements typically in the 10–25% range from baseline at month 6 — but consistent across well-designed trials.

Mesotherapy has a smaller and more heterogeneous evidence base. The variation is partly because "mesotherapy" describes a delivery method (intradermal injection of a cocktail), not a single product. Different cocktails have different evidence. Generally, mesotherapy series report patient-reported improvement at rates similar to PRP in early-stage patients, but with more outcome variation and fewer head-to-head trials.

This is the honest summary clinics should communicate to patients: PRP has more trial data; mesotherapy works well in practice but with less standardised evidence. Both are reasonable, both produce real outcomes in appropriate patients.

The protocol that drives outcomes

The variable that moves outcomes more than treatment choice is protocol consistency. A clinic that runs the same PRP centrifuge timing every session, the same injection grid, the same intervals, will outperform a clinic that runs better-evidence treatments inconsistently.

The PRP protocol detail is in PRP protocol for hair loss: a step-by-step reference. The mesotherapy protocol parallels it: the same patient selection rigor, the same injection grid (1 cm spacing), the same depth (3–5 mm), the same session intervals (monthly during loading, then every 3–6 months for maintenance).

Combining PRP and mesotherapy

Most patients in clinics offering both treatments end up on a combined protocol — PRP plus mesotherapy in the same session, or PRP loading followed by mesotherapy maintenance. The combined approach is widely practised and widely defensible clinically.

Two combination patterns are most common:

Pattern A — Combined session. PRP and mesotherapy injected in the same visit, typically PRP first (in target zones for growth factor delivery) followed by mesotherapy in adjacent zones for vitamin/mineral support. Total session 45–60 minutes.

Pattern B — Sequential phases. PRP loading (4 monthly sessions), then transition to mesotherapy maintenance (every 3 months). This pattern uses PRP's stronger evidence at the loading phase and mesotherapy's flexibility at maintenance.

Pricing combined or sequential protocols is covered in the rollout guide — building a PRP program in your clinic — and the team-side training is in mesotherapy training course for doctors.

Contraindications side by side

The unified contraindication list — bleeding disorders, anticoagulant therapy without clearance, active scalp infection, active malignancy — applies to both treatments. The differential contraindications are mostly about formulation specifics: citrate sensitivity points to mesotherapy; cocktail hypersensitivity points to PRP.

What patients ask in consultation

Three questions come up repeatedly. The honest answers are short.

"Which one will work better for me?" Both work for the same patient profile. The choice is more about preferences (blood draw, appointment length, cost) than about expected outcome difference for early-stage cases.

"How long until I see results?" Both treatments require 3–4 loading sessions before visible changes. Patient-reported improvement at month 3 is partial; meaningful photographic evidence at month 6.

"Will this stop my hair loss?" Neither will completely halt androgenetic alopecia in a male patient with active progression. They slow progression and improve density modestly. The honest framing is: "These treatments support the hair you have. They are part of a long-term plan, not a one-time fix."

Audit cadence is the protocol

Whichever treatment a patient is on — PRP, mesotherapy, or combined — the month-six audit determines what happens next. Standardised photography against baseline, patient-reported satisfaction, hair pull test or trichoscopy where available, and a documented decision: continue maintenance, repeat loading, switch protocol, or refer for surgical assessment.

A clinic that runs this audit consistently improves outcomes across both treatment lines over time. A clinic that doesn't audit is, by year two, running the same treatments differently than year one without realising it.

Choosing what to offer first

A clinic just launching its regenerative service has a choice: lead with PRP, lead with mesotherapy, or launch both together. Most clinics launch both because the patient pool that wants one usually wants the other. Where capital is constrained, lead with PRP — equipment cost is comparable to mesotherapy stock, but the evidence base supports stronger consultation conversations. The clinical training programmes for both are widely available; the curriculum and selection criteria are in PRP hair treatment training for clinics.

The decision matters less than the discipline that follows it. Pick a protocol, document it, audit it, refine it. That sequence works regardless of which treatment a clinic leads with.

When to refer to surgical assessment

PRP and mesotherapy work for patients with active follicles. Patients beyond the threshold of medical management — Norwood VI–VII in men, Ludwig III in women — should be referred to surgical assessment rather than enrolled in injection courses. The honest framing in consultation: "These treatments support the hair you have. At your stage, the conversation is about restoring what's already gone, which is a different decision." The decision-making framework for that next step sits in the broader hair transplant training course for doctors discussion of patient selection at consultation. Clinics that route advanced patients into injection-only courses end up with disappointed patients and complaint volume that hurts the broader regenerative service.